An international consensus establishes dosing recommendations of methotrexate for psoriasis treatment and identifies current knowledge gaps on the topic.
Researchers investigated the generalizability of a previous study finding that increased mean corpuscular volume complements clinical response in psoriatic arthritis.
Treatment with brodalumab was well tolerated and produced high levels of skin clearance over 120 weeks in patients with moderate to severe plaque psoriasis, according to results of a post hoc analysis of phase 2 and 3 clinical trials of brodalumab published in the Journal of the European Academy of Dermatology and Venereology. To address…
Authors of a systematic review compared the efficacy and safety of systemic therapies in the treatment of manifestations of active psoriatic arthritis.